Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib versus placebo with dynamic contrast-enhanced ultrasound monitoring in chemo-refractory metastatic colorectal cancer
ISRCTN70833965Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Sep 2012
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in colorectal cancer (CRC) and metastatic colorectal adenocarcinoma (mCRC) comparing Axitinib monotherapy with Placebo (2 arms). Primary endpoint: Progression-free survival. Started Sep 2012; status: completed.
02
Drugs
axitinib
03
Conditions
colorectal cancer (CRC)metastatic colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on ISRCTN70833965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN70833965.